APA
Dillman R. O., Nanci A. A., Williams S. T., Kim R. B., Hafer R. L., Coleman C. L., Wang P. C., Duma C. M., Chen P. V., Selvan S. R., Cornforth A. N. & DePriest C. (20110215). Durable complete response of refractory, progressing metastatic melanoma after treatment with a patient-specific vaccine. : Cancer biotherapy & radiopharmaceuticals.
Chicago
Dillman Robert O, Nanci Andreea A, Williams Scott T, Kim Richard B, Hafer Russell L, Coleman Colleen L, Wang Peter C, Duma Christopher M, Chen Peter V, Selvan Senthamil R, Cornforth Andrew N and DePriest Carol. 20110215. Durable complete response of refractory, progressing metastatic melanoma after treatment with a patient-specific vaccine. : Cancer biotherapy & radiopharmaceuticals.
Harvard
Dillman R. O., Nanci A. A., Williams S. T., Kim R. B., Hafer R. L., Coleman C. L., Wang P. C., Duma C. M., Chen P. V., Selvan S. R., Cornforth A. N. and DePriest C. (20110215). Durable complete response of refractory, progressing metastatic melanoma after treatment with a patient-specific vaccine. : Cancer biotherapy & radiopharmaceuticals.
MLA
Dillman Robert O, Nanci Andreea A, Williams Scott T, Kim Richard B, Hafer Russell L, Coleman Colleen L, Wang Peter C, Duma Christopher M, Chen Peter V, Selvan Senthamil R, Cornforth Andrew N and DePriest Carol. Durable complete response of refractory, progressing metastatic melanoma after treatment with a patient-specific vaccine. : Cancer biotherapy & radiopharmaceuticals. 20110215.